Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
2457PDF: 2966Supplementary: 357Appendix: 293 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1295pdf: 294Supplementary Material: 48HTML: 158 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
887PDF: 266Supplementary: 161Appendix: 122HTML: 76 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
867PDF: 232Supplementary: 168Appendix: 121HTML: 53 -
Dyslipidemia and stroke-related mortality in the United States: a nationwide analysis for 2010-2020
344PDF: 97Supplementary: 22HTML: 29 -
Coronary artery calcium scoring. What clinicians need to know
1472PDF: 425HTML: 173 -
-
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
2126PDF: 576SUPPLEMENTARY MATERIAL: 321GRAPHICAL ABSTRACT: 281HTML: 44 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
267PDF: 295Supplementary: 160HTML: 36 -
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1234PDF: 317Supplementary: 171HTML: 142 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2857PDF: 708Conflict of interest: 335SUPPLEMENTARY MATERIAL: 283HTML: 83 -
Epidemiology of peripartum cardiomyopathy in Africa
2493PDF: 545HTML: 127 -
Evolving targets for heart failure: the journey so far
2158pdf: 383HTML: 4

